GRANT ALERT! Harrington Rare Disease Scholar Award Program sponsored by Takeda is accepting proposals

Program Seeks to Accelerate the Development of Cures and Therapies for Rare Diseases

The Harrington Rare Disease Scholar Award was created to advance breakthrough research into novel treatments for rare diseases. The Harrington Rare Disease Scholar Program is sponsored by Takeda Pharmaceutical Company Limited and overseen by Harrington Discovery Institute. To learn more about the collaboration, please go to About Our Partnership.

The Harrington Rare Disease Scholar Program will provide funding and hands-on drug development guidance for two years to U.S.-based MD and PhD researchers whose discoveries show promise for translation into novel medicines for rare diseases.

DATES TO KNOW

July 19, 2017
Letter of Intent Deadline
Download Letter of Intent Guidelines (PDF)

October 4, 2017
Full Application Deadline (for those invited)

February 2018
Awardees Notified

Content courtesy of http://www.uhhospitals.org (full link here).